The instruction for medical use
of NAFAZOLIN-DF medicine
the Trade name
the International unlicensed
name Naphazoline Dosage Form Spray of Nasal 0.1% on 10 ml
of 10 ml of drug contain
active agent – naphazoline nitrate – 10 mg
excipients – boric acid, water
the Transparent colourless or slightly yellowish liquid purified the Description.
of Antikongestanta and other nasal drugs for topical administration.
The ATX R01AA08 CODE
Pharmacokinetics Therapeutic Effect properties of naphazoline develops in 5 minutes after injection of drug and proceeds till 8 o’clock. At topical administration, naphazoline can be soaked up in a system blood stream and have systemic action.
Alpha adrenomimetik. Naphazoline is a sympathomimetic with direct promoting effect on alfa2-adrenoceptors. Owing to vasoconstrictive action puffiness, hyperaemia, exudation decreases. At intranasal use, naphazoline promotes simplification of nasal breath in rhinitises. Promotes opening and expansion of entrance channels of adnexal bosoms of a nose and release of Eustachian tubes. It promotes outflow of a secret and prevents sedimentation of bacteria on mucous a nose.
– acute rhinitis
– hay cold
– hyperaemia and puffiness of mucous membranes of upper airways after operations
– a rinoskopiya
the Route of administration and doses
apply Spray of nasal 0.1% to adults and children 15 years on the 1st injection in each nasal course 3 times a day are more senior.
Course of treatment of 5-7 days. The repeated course of treatment is appointed by the doctor.
– irritation of a mucous membrane
– the increased arterial blood pressure, tachycardia
– nausea, a headache
– a reactive hyperemia of a mucous membrane
– at use – flowed more than 1 week a mucous membrane, atrophic rhinitis
of the Contraindication
– hypersensitivity to drug components
– an arterial hypertension, tachycardia, the profound atherosclerosis
– a serious illness of eyes
– a hyper thyroidism
– chronic rhinitis
– a concomitant use of inhibitors of a monoaminooxidase and the period up to 14 days after the end of their use
Drug slows down absorption of mestnoanesteziruyushchy means (extends their action when carrying out surface anesthesia).
It is incompatible with monoaminooxidase inhibitors.
instructions Nafazolin-DF with care it is applied at persons with labile arterial blood pressure.
Pregnancy and a lactation
Use of drug at pregnancy and in the period of a lactation perhaps only according to strict indications when the expected therapeutic effect for mother exceeds potential risk for a fruit or the child.
Features of influence of medicine on ability to run the vehicle or potentially dangerous mechanisms
Considering side effects of drug it is necessary to be careful at control of motor transport or potentially dangerous mechanisms.
Symptoms – decrease in body temperature, bradycardia, arterial hypertension.
Treatment is symptomatic.
A form of release and packing
On 10 ml of drug in polypropylene bottles with a cover – the spray and a protective cap. On one bottle together with the instruction for medical use in the state and Russian languages place in a pack cardboard.
To Store storage conditions in the place protected from light, at a temperature from 18 °C to 25 °C.
To store out of children’s reach!
After an expiration date not to apply a period of storage.
DOSFARM LLP Producer, Kazakhstan, 050034, Almaty, Chaplygin St., 3.
The owner of the registration certificate
of DOSFARM LLP, Kazakhstan
the Address of the organization accepting in the territory of the Republic of Kazakhstan claims from consumers on quality of products
of DOSFARM LLP, the Republic of Kazakhstan, Almaty, st. Chaplygina, 3, ph./fax: (727) 253-03-88, el. address: firstname.lastname@example.org